Jaguar Health Inc Share Price Nasdaq
Equities
US47008L1061
Biotechnology & Medical Research
Sales 2024 * | 15.11M 1.21B | Sales 2025 * | 22.66M 1.81B | Capitalization | 82.31M 6.59B |
---|---|---|---|---|---|
Net income 2024 * | -26M -2.08B | Net income 2025 * | -21M -1.68B | EV / Sales 2024 * | 5.45 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 3.63 x |
P/E ratio 2024 * |
-3.31
x | P/E ratio 2025 * |
-4.26
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.16% |
Latest transcript on Jaguar Health Inc
Managers | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 30/04/19 |
Chief Tech/Sci/R&D Officer | 60 | 30/04/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 05/06/13 |
James Bochnowski
CHM | Chairman | 80 | 31/01/14 |
John Micek
BRD | Director/Board Member | 71 | 31/03/16 |
1st Jan change | Capi. | |
---|---|---|
+3.43% | 106B | |
+7.02% | 23.47B | |
-14.79% | 21.9B | |
-7.05% | 18.77B | |
-38.55% | 17.85B | |
-9.39% | 16.78B | |
+6.65% | 14.41B | |
+34.72% | 12.86B | |
+314.88% | 8.78B |